RESUMO
Preliminary clinical evidence suggests that metformin has TSH lowering effects in patients with T2DM and hypothyroidism or in those with TSH serum levels in the upper normal value. Also, metformin may exert a protective role against thyroid nodules growth in patients without insulin-resistance. The cross-talk between tyrosine kinase receptors and the G protein-coupled receptors (which the TSHR belongs to) has been already shown and IRS1 may represent the hub link between TSHR and IR pathways. By influencing IRS1 phosphorylation pattern, metformin may sensitize TSHR to TSH, thus explaining the findings of clinical studies. However, the existence of this molecular pathway must be confirmed through proper studies and further prospective randomized placebo-controlled studies are needed to confirm this hypothesis.
Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Proteínas Substratos do Receptor de Insulina/metabolismo , Metformina/uso terapêutico , Receptores da Tireotropina/metabolismo , Nódulo da Glândula Tireoide/prevenção & controle , Tireotropina/metabolismo , Diabetes Mellitus Tipo 2/patologia , Seguimentos , Humanos , Fosforilação , Prognóstico , Estudos Prospectivos , Estudos Retrospectivos , Nódulo da Glândula Tireoide/metabolismoRESUMO
Thermal ablation (TA) procedures, such as radiofrequency ablation and laser ablation, are used for the treatment of benign thyroid nodules. Short-term studies (<2 years) have demonstrated that TA is an effective and safe procedure to improve cosmetic or symptomatic problems. However, studies including a longer follow-up period show that treated thyroid nodules can increase in size after 2 to 3 years. Several studies suggest that this results from regrowth at the undertreated nodule margins. Here, we review current data on regrowth after TA and describe factors related to it and possible approaches to prevent it.
Assuntos
Recidiva Local de Neoplasia/prevenção & controle , Recidiva Local de Neoplasia/cirurgia , Nódulo da Glândula Tireoide/prevenção & controle , Nódulo da Glândula Tireoide/cirurgia , Humanos , Terapia a Laser , Ablação por Radiofrequência , Resultado do TratamentoRESUMO
A potential radiation protection method to reduce the risk of adverse health outcomes in the case of accidental radioactive iodine release is the administration of potassium iodide (KI). Although KI administration is recommended by WHO's Guidelines for Iodine Prophylaxis following Nuclear Accidents, a systematic review of the scientific evidence for the guidelines is lacking. Therefore, this study aims to systematically review the effects of KI administration in the case of accidental radioactive iodine release on thyroid cancer, hypothyroidism and benign thyroid nodules. We applied standard systematic review methodology for a search of the literature, selection of eligible studies, data extraction, assessment of risk of bias, assessment of heterogeneity, data synthesis, and the assessment of the quality of the evidence. We searched MEDLINE (via PubMed) and EMBASE. We found one cross-sectional study, one analytic cohort study and two case-control studies relating to our question. The number of participants ranged from 886-12 514. Two studies were conducted in children and two other studies in children and adults. It was not possible to conduct a meta-analysis. We identified low to very low-quality evidence that KI administration after a nuclear accident resulted in a reduction of the risk of thyroid cancer in children; however, the KI administration and dose was not well described in the studies. None of the studies investigated the effects of KI administration in the case of a nuclear accident on hypothyroidism and benign thyroid nodules. Low to very low-quality evidence suggests that KI intake following a nuclear accident may reduce the risk of thyroid cancer in children. No conclusions can be drawn about the effectiveness of KI intake with respect to the prevention of hypothyroidism and benign thyroid nodules.
Assuntos
Hipotireoidismo/prevenção & controle , Radioisótopos do Iodo/toxicidade , Iodeto de Potássio/uso terapêutico , Lesões por Radiação/prevenção & controle , Proteção Radiológica/métodos , Protetores contra Radiação/uso terapêutico , Liberação Nociva de Radioativos , Neoplasias da Glândula Tireoide/prevenção & controle , Nódulo da Glândula Tireoide/prevenção & controle , Humanos , Guias de Prática Clínica como AssuntoRESUMO
OBJECTIVES: We comprehensively estimated the prevalence of goiter and thyroid nodules (TNs) before and after the implementation of the Universal Salt Iodization (USI) program in mainland China and provided information for creating effective health policies. METHODS: PubMed, Google Scholar, CNKI, Chinese Wanfang and Chongqing VIP databases were searched for relevant studies from Jan 1985 to Feb 2014. Data from eligible citations were extracted by two independent reviewers. All analyses were performed with Stata 11.0 and SPSS 17.0. RESULTS: Eligible articles (Nâ=â31; 4 in English and 27 in Chinese) included 52 studies (15 about goiter rates made before 1996 and 14 afterwards, and 23 about TNs). Our meta-analysis suggests a pooled prevalence for goiter before and after 1996 and for TNs of 22.8% (95% CI: 15.3%, 30.3%), 12.6% (95% CI: 9.4%, 15.8%) and 22.7% (95% CI: 18.3%, 27.0%), respectively. Egger's test of three independent categories revealed no evidence of publication bias (pâ=â0.101, 0.148 and 0.113, respectively). CONCLUSIONS: The prevalence of goiter was reduced by almost half after 1996 in mainland China, so the USI program was considered beneficial. However, subgroup analysis suggests that both insufficient and excess iodine may be associated with goiter. The prevalence of goiter and TNs increased significantly after 2002, suggesting a risk of excessive iodine intake. Thus, salt iodization standardizations should be set according to local conditions.
Assuntos
Bócio/tratamento farmacológico , Bócio/epidemiologia , Iodo/uso terapêutico , Cloreto de Sódio na Dieta/uso terapêutico , Nódulo da Glândula Tireoide/tratamento farmacológico , Nódulo da Glândula Tireoide/epidemiologia , China/epidemiologia , Bases de Dados Factuais , Bócio/prevenção & controle , Política de Saúde , Humanos , Prevalência , Nódulo da Glândula Tireoide/prevenção & controleRESUMO
OBJECTIVE: Differentiated thyroid cancer (DTC) commonly occurs in women of child-bearing age and represents the second most frequent tumor diagnosed during pregnancy only behind breast cancer. It is possible that associated physiological changes could favor tumor development and growth. However, few data are available about the outcome of DTC related to pregnancy, leading to conflicting results. METHODS: Among the study population, 340 patients with DTC <45 years old were retrospectively studied. Patients were divided into three groups according to the time of tumor diagnosis in respect of pregnancy. Group 1, diagnosis of DTC at least 2 years after delivery; group 2, diagnosis during pregnancy or within the second year after delivery; and group 3, nulliparous patients at the time of diagnosis. We evaluated clinical outcome and immunohistochemical expression of estrogen receptor α (ERα), ERß, progesterone receptor, and aromatase. We also analyzed the gene expression of NIS (SLC5A5) and the prevalence of BRAF(V600E) mutations. RESULTS: Persistence/recurrence of disease was significantly higher in group 2 patients than control groups (P=0.023). No significant differences were observed in other clinical parameters. Furthermore, no differences among the groups were recorded about ER pattern, NIS expression, and BRAF mutations. CONCLUSIONS: Persistence/recurrence of DTC is significantly higher in pregnant patients, suggesting that pregnancy could really exert a negative prognostic role in patients with DTC. The underlying mechanisms are not yet clarified and further studies are required. Our results suggest that a more careful follow-up is needed when diagnosis of DTC occurs during pregnancy or shortly after.
Assuntos
Complicações Neoplásicas na Gravidez/diagnóstico , Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/diagnóstico , Adolescente , Adulto , Transformação Celular Neoplásica , Terapia Combinada/efeitos adversos , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/prevenção & controle , Estadiamento de Neoplasias , Período Pós-Parto , Gravidez , Complicações Neoplásicas na Gravidez/patologia , Complicações Neoplásicas na Gravidez/prevenção & controle , Complicações Neoplásicas na Gravidez/terapia , Prognóstico , Cintilografia , Compostos Radiofarmacêuticos/efeitos adversos , Compostos Radiofarmacêuticos/uso terapêutico , Indução de Remissão , Estudos Retrospectivos , Glândula Tireoide/diagnóstico por imagem , Glândula Tireoide/metabolismo , Glândula Tireoide/cirurgia , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/prevenção & controle , Neoplasias da Glândula Tireoide/terapia , Nódulo da Glândula Tireoide/diagnóstico , Nódulo da Glândula Tireoide/patologia , Nódulo da Glândula Tireoide/prevenção & controle , Nódulo da Glândula Tireoide/terapia , Tireoidectomia/efeitos adversos , Adulto JovemRESUMO
BACKGROUND: The controversy that iodized salt may increase the risk of thyroid disorders has arisen in China during the past several years. OBJECTIVE: This study aimed to explore whether iodized salt increased the risk of thyroid nodule among a Chinese population. DESIGN: A cross-sectional study was conducted in Hangzhou, China, in 2010. Iodized salt intake, urinary iodine concentration (UIC), and thyroid nodule (by ultrasonography) were measured in 9412 adults. The associations of iodized salt with thyroid nodule were evaluated by using multiple mixed logistic regression models. RESULTS: The prevalence of thyroid nodule among men and women was 24.1% and 34.7%, respectively. Adults consuming noniodized salt had an increased risk of thyroid nodule (OR: 1.36; 95% CI: 1.01, 1.83). Similarly, compared with moderate salt appetite, mild salt appetite was associated with an increased risk of thyroid nodule among all adults (OR: 1.19; 95% CI: 1.03, 1.37) and among women (OR: 1.23; 95% CI: 1.03, 1.46). Furthermore, those who consumed neither iodized salt nor milk had a higher risk of thyroid nodule (OR: 1.72; 95% CI: 1.21, 2.43) than did those who consumed both iodized salt and milk. In addition, an increased risk of thyroid nodule (OR: 1.25; 95% CI: 1.07, 1.45) was observed among both pooled samples and women with low UIC. CONCLUSIONS: These findings indicate that low iodine intake may increase the risk of thyroid nodule in a Chinese population, particularly in women. Hence, the Universal Salt Iodization program may be indispensable for a coastal Chinese population such as that living in Hangzhou. This trial was registered at clinicaltrials.gov as NCT01838629.
Assuntos
Iodo/deficiência , Cloreto de Sódio na Dieta/administração & dosagem , Glândula Tireoide/patologia , Nódulo da Glândula Tireoide/etiologia , Adulto , Idoso , Animais , Apetite , Estudos Transversais , Feminino , Humanos , Iodo/administração & dosagem , Iodo/uso terapêutico , Masculino , Pessoa de Meia-Idade , Leite , Prevalência , Fatores de Risco , Fatores Sexuais , Cloreto de Sódio na Dieta/uso terapêutico , Nódulo da Glândula Tireoide/epidemiologia , Nódulo da Glândula Tireoide/prevenção & controleRESUMO
CONTEXT: Recurrence rate, after aspiration, in cystic thyroid nodules is very high. Interstitial laser photocoagulation (ILP) is a minimally invasive procedure that reduces the need for surgery in patients with a benign solid thyroid nodule. OBJECTIVE: The aim of the study was to evaluate the efficacy of ILP on remission rates in recurrent, predominantly cystic thyroid nodules. DESIGN AND METHODS: Forty-four consecutive outpatients with a symptomatic, recurrent, and cytologically benign cystic (cyst volume ≥ 2 mL) thyroid nodule were randomized to a single aspiration with (n = 22) or without (n = 22) subsequent ILP and followed up after 1, 3, and 6 months. RESULTS: Successful outcome (cyst volume ≤ 1 mL) was obtained in 15 of 22 (68%) patients in the ILP group, compared to 4 of 22 (18%) in the aspiration group (P = .002). In the ILP group, the solid part of the nodule was reduced from a median of 1.8 to 1.0 mL (P = .02). In the aspiration-alone group, neither the cyst volume nor the solid nodule volume was significantly reduced. The reduction in median visual analog score (0-10 cm) for pressure symptoms was significantly higher in the ILP group (from 3.0 to 0.0 cm) than in the aspiration-alone group (from 4.0 to 3.5 cm) (P = .006, between groups). No major side effects occurred, and thyroid function was unaffected throughout. CONCLUSIONS: US-guided aspiration and subsequent ILP of benign recurrent predominantly cystic thyroid nodules is safe. It significantly reduces recurrence rate, the volume of the solid nodule component, and pressure symptoms. ILP constitutes an important alternative to surgery in such patients.
Assuntos
Cistos/cirurgia , Fotocoagulação a Laser , Recidiva Local de Neoplasia/cirurgia , Glândula Tireoide/cirurgia , Nódulo da Glândula Tireoide/cirurgia , Adulto , Idoso , Terapia Combinada/efeitos adversos , Cistos/patologia , Cistos/fisiopatologia , Cistos/prevenção & controle , Dinamarca , Feminino , Seguimentos , Humanos , Fotocoagulação a Laser/efeitos adversos , Masculino , Pessoa de Meia-Idade , Cervicalgia/etiologia , Cervicalgia/prevenção & controle , Recidiva Local de Neoplasia/fisiopatologia , Recidiva Local de Neoplasia/prevenção & controle , Satisfação do Paciente , Complicações Pós-Operatórias/prevenção & controle , Indução de Remissão , Sucção/efeitos adversos , Glândula Tireoide/patologia , Glândula Tireoide/fisiopatologia , Nódulo da Glândula Tireoide/patologia , Nódulo da Glândula Tireoide/fisiopatologia , Nódulo da Glândula Tireoide/prevenção & controle , Carga TumoralRESUMO
Thyroid cancer is the most common cancer among Korean women. However, there are few data on dietary factors related to thyroid cancer risk. The objective of the present study was to evaluate the association between raw vegetables and fruits intake and thyroid cancer in a case-control study. We included 111 histologically confirmed malignant thyroid cancer cases and 115 benign cases. Controls who did not have nodules in thyroid ultrasonography were matched to cases by age (± 2 years). Food and nutrient intakes were estimated using a quantitative FFQ with 121 items. Conditional logistic regression analysis was used to obtain OR and corresponding 95 % CI. The intake of total vegetables was not associated with malignant thyroid cancer, but inversely associated with benign cases. High raw vegetable intake was inversely associated with thyroid cancer risk both in malignant and benign cases (P for trend = 0·01 in both malignant and benign cases). Among fruits, persimmon intake had an inverse association with thyroid cancer risk in both malignant and benign cases (P for trend = 0·06 in malignant cases; P for trend = 0·01 in benign cases) and tangerine intake had an inverse association in malignant cases (P for trend = 0·03). The frequency of consumption of raw vegetables and persimmon also had a consistent inverse association in both malignant and benign cases. These results suggest that high consumption of raw vegetables, persimmons and tangerines may decrease thyroid cancer risk and help prevent early-stage thyroid cancer.
Assuntos
Dieta , Frutas , Glândula Tireoide/diagnóstico por imagem , Neoplasias da Glândula Tireoide/prevenção & controle , Nódulo da Glândula Tireoide/prevenção & controle , Verduras , Centros Médicos Acadêmicos , Adulto , Idoso , Estudos de Casos e Controles , Citrus , Dieta/efeitos adversos , Dieta/etnologia , Diospyros , Feminino , Humanos , Modelos Logísticos , Pessoa de Meia-Idade , República da Coreia/epidemiologia , Fatores de Risco , Inquéritos e Questionários , Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/diagnóstico por imagem , Neoplasias da Glândula Tireoide/epidemiologia , Neoplasias da Glândula Tireoide/etiologia , Nódulo da Glândula Tireoide/diagnóstico por imagem , Nódulo da Glândula Tireoide/epidemiologia , Nódulo da Glândula Tireoide/etiologia , Ultrassonografia , Adulto JovemRESUMO
OBJECTIVE: To discuss the risk of recurrence in patients with differentiated thyroid cancer and emphasize the importance of risk-group stratification. METHODS: Common risk factors associated with recurrent thyroid cancer are outlined, and appropriate management strategies are reviewed. RESULTS: The overall prognosis in patients with differentiated thyroid cancer is excellent. Factors associated with recurrent thyroid cancer include extrathyroidal extension of the primary tumor, bulky nodal metastatic lesions, macroscopic local invasion, and aggressive histologic subtypes. The locoregional recurrence and mortality are higher in patients with high-risk thyroid cancers. Patients initially presenting with locally aggressive and advanced thyroid cancer have a higher incidence of recurrent disease in the thyroid bed or nodal metastasis. These patients also have a high incidence of distant metastatic lesions. Locally recurrent thyroid cancer may be seen in more than 25% of patients with aggressive differentiated thyroid cancer. Recurrent disease in the thyroid bed can be a difficult problem to manage because of the proximity of the tumor to the recurrent laryngeal nerve, visceral structures in the central compartment, and occasional involvement of the trachea or larynx. External beam radiation therapy after surgical treatment may be important for better local control in the thyroid bed region, especially in patients with poorly differentiated histologic features. The role of additional radioiodine therapy remains undefined at this stage. CONCLUSION: Management of patients with recurrent thyroid cancer necessitates a true multidisciplinary approach. These patients require close follow-up, with cross-sectional imaging and positron emission tomographic scanning in selected individuals.
Assuntos
Transformação Celular Neoplásica/patologia , Recidiva Local de Neoplasia/epidemiologia , Recidiva Local de Neoplasia/terapia , Neoplasias Complexas Mistas/epidemiologia , Neoplasias Complexas Mistas/terapia , Neoplasias da Glândula Tireoide/epidemiologia , Neoplasias da Glândula Tireoide/terapia , Humanos , Recidiva Local de Neoplasia/diagnóstico , Recidiva Local de Neoplasia/prevenção & controle , Neoplasias Complexas Mistas/diagnóstico , Neoplasias Complexas Mistas/prevenção & controle , Guias de Prática Clínica como Assunto , Prognóstico , Risco , Tireoglobulina/sangue , Neoplasias da Glândula Tireoide/diagnóstico , Neoplasias da Glândula Tireoide/prevenção & controle , Nódulo da Glândula Tireoide/diagnóstico , Nódulo da Glândula Tireoide/epidemiologia , Nódulo da Glândula Tireoide/prevenção & controle , Nódulo da Glândula Tireoide/terapiaRESUMO
OBJECTIVE: To report a case of subacute thyroiditis manifesting as a thyroid mass, vocal cord paralysis, and hypercalcemia. METHODS: We describe the clinical, laboratory, and radiologic findings in a patient with an unusual clinical course of subacute thyroiditis. RESULTS: A 65-year-old woman presented with a hoarse voice and an enlarging tender mass in the right side of the neck. On admission, thyroid function was consistent with thyrotoxicosis from subacute thyroiditis. Laboratory studies showed a corrected serum calcium concentration of 11.4 mg/dL, intact parathyroid hormone of 125 pg/mL, 25-hydroxyvitamin D of 12 ng/mL, and creatinine of 1.8 mg/dL. Computed tomography of the neck without use of a contrast agent showed a heterogeneous mass in the right side of the neck in conjunction with deviation of the trachea from right to left but without invasion of the trachea. Thyroid ultrasonography disclosed a heterogeneous mass in the right thyroid lobe measuring 4.7 cm by 5.5 cm by 4.5 cm. Flexible laryngoscopy revealed right vocal cord paralysis. Treatment with a course of prednisone yielded normalization of the serum calcium level, improvement in her voice, and a decrease in size of the thyroid mass. Four months after initial presentation of the patient, thyroid hormone levels became normal, she was clinically euthyroid, and she had a full recovery of her voice. Her serum calcium concentration was normal (9.8 mg/dL) in association with a near-normal parathyroid hormone level of 90 pg/mL. The 25-hydroxyvitamin D and creatinine values were also normal. Repeated thyroid ultrasonography showed a smaller right thyroid lobe with a dominant nodule measuring 2.0 cm by 1.3 cm by 1.4 cm in the right upper pole. CONCLUSION: This case illustrates that subacute thyroiditis can have the unusual initial manifestations of a thyroid mass, vocal cord paralysis, and hypercalcemia. In similar patients, a trial of corticosteroid therapy may be warranted in an effort to improve clinical symptoms and thus avoid unnecessary surgical treatment.
Assuntos
Hipercalcemia/etiologia , Nódulo da Glândula Tireoide/etiologia , Tireoidite Subaguda/fisiopatologia , Paralisia das Pregas Vocais/etiologia , Idoso , Anti-Inflamatórios/uso terapêutico , Feminino , Rouquidão/etiologia , Rouquidão/prevenção & controle , Humanos , Hipercalcemia/prevenção & controle , Prednisona/uso terapêutico , Nódulo da Glândula Tireoide/prevenção & controle , Tireoidite Subaguda/tratamento farmacológico , Resultado do Tratamento , Paralisia das Pregas Vocais/prevenção & controleAssuntos
Hipotireoidismo Congênito/diagnóstico por imagem , Hipotireoidismo Congênito/tratamento farmacológico , Terapia de Reposição Hormonal , Glândula Tireoide/diagnóstico por imagem , Hormônios Tireóideos/sangue , Tiroxina/uso terapêutico , Hipotireoidismo Congênito/sangue , Monitoramento de Medicamentos , Humanos , Recém-Nascido , Masculino , Nódulo da Glândula Tireoide/prevenção & controle , Tiroxina/sangue , Resultado do Tratamento , UltrassonografiaRESUMO
Statins have marked beneficial effects on lipid profile, but also have pleiotropic actions. A previous study in an iodine-deficient area suggested that statin use is associated with reduced thyroid volume and nodularity. We performed this study to investigate how long-term statin use in type 2 diabetic patients affects thyroid nodularity in iodine-sufficient area.We recruited euthyroid type 2 diabetic patients, receiving statin therapy continuously for at least 5 years (statin group) and, age and sex matched statin-naive type 2 diabetic patients (control group). Subjects with past history of cancer, thyroid disease or treatment with lithium or amiodarone; family history of thyroid cancer; palpable goiter or thyroid nodule, and/or positive thyroperoxidase antibody were excluded. The prevalence, number, and volume of thyroid nodules, size of thyroid were evaluated in all subjects by high resolution ultrasound.Prevalence of non-palpable thyroid nodules of statin group (n=70) and control group (n=98) were 51 and 53%, respectively. There was no difference of prevalence, number, and volume of non-palpable thyroid nodules and size of thyroid between statin and control group. But, the patients aged between 60 and 65 years from statin group showed lower prevalence of non-palpable thyroid nodules than the patients with same age interval from control group (4 out of 12 patients, 33%, statin group; 19 out of 27 patients, 70%, control group; P=0.04).Long-term statin use in elderly type 2 diabetic patients was associated with lesser prevalence of thyroid nodules in an iodine-sufficient area. Our data might support a possible antiproliferative effect of statins on thyroid in old type 2 diabetic patients. But, the effect was not as strong as that in an iodine-deficient area and further studies with enough numbers of subjects and revised design will be needed.
Assuntos
Diabetes Mellitus Tipo 2/complicações , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Hiperlipidemias/tratamento farmacológico , Hipolipemiantes/uso terapêutico , Nódulo da Glândula Tireoide/prevenção & controle , Fatores Etários , Idoso , Proliferação de Células/efeitos dos fármacos , Feminino , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos , Hiperlipidemias/complicações , Hipolipemiantes/administração & dosagem , Hipolipemiantes/efeitos adversos , Iodo/administração & dosagem , Masculino , Pessoa de Meia-Idade , Tamanho do Órgão/efeitos dos fármacos , Prevalência , Reprodutibilidade dos Testes , República da Coreia/epidemiologia , Glândula Tireoide/diagnóstico por imagem , Glândula Tireoide/efeitos dos fármacos , Glândula Tireoide/patologia , Nódulo da Glândula Tireoide/diagnóstico por imagem , Nódulo da Glândula Tireoide/epidemiologia , Nódulo da Glândula Tireoide/patologia , Fatores de Tempo , Carga Tumoral/efeitos dos fármacos , UltrassonografiaRESUMO
Mild iodine deficiency (MID) is a long-standing problem in Belgium and was recognized only recently as public health issue by the Ministry of Health (MOH). The main MID-related health problems in Belgium are a high prevalence of thyroid nodules and multinodular goiter. The economic cost of thyroid nodular disease only in Belgium was estimated at about 40 millions per year. The Belgian health authorities adopted a selective strategy to optimize iodine intake through the fortification of bread with iodized salt. A progressive, step-by-step increase of the iodine content of salt was chosen in order to minimize the incidence of hyperthyroidism. MOH monitors this strategy by assessing periodically the urinary iodine concentration in school-aged children and pregnant women, as well as by a yearly follow-up of TSH concentrations in all Belgian newborns. Although the implementation of this strategy was an important step, the main drawback of the current situation is the absence of a legal framework to support the strategy. The utilization of iodized salt in bread on a voluntary basis was endorsed by the bakery industry and MOH. However a legal framework is required to assure the effectiveness and continuity of the program and to avoid a higher than optimal iodine intake in the population.
Assuntos
Iodo/deficiência , Cloreto de Sódio na Dieta/administração & dosagem , Nódulo da Glândula Tireoide/dietoterapia , Adulto , Bélgica/epidemiologia , Pão/economia , Criança , Feminino , Alimentos Fortificados/economia , Custos de Cuidados de Saúde/estatística & dados numéricos , Humanos , Hipertireoidismo/dietoterapia , Hipertireoidismo/epidemiologia , Hipertireoidismo/prevenção & controle , Incidência , Recém-Nascido , Iodo/administração & dosagem , Iodo/economia , Iodo/urina , Pessoa de Meia-Idade , Inquéritos Nutricionais/estatística & dados numéricos , Gravidez , Prevalência , Cloreto de Sódio na Dieta/economia , Nódulo da Glândula Tireoide/economia , Nódulo da Glândula Tireoide/epidemiologia , Nódulo da Glândula Tireoide/prevenção & controleRESUMO
BACKGROUND: Several surveys in the last 50 years have repeatedly indicated that Belgium is affected by mild iodine deficiency. Within the framework of the national food and health plan in Belgium, a selective, progressive, and monitored strategy was proposed in 2009 to optimize iodine intake. The objective of the present study was to perform a health economic evaluation of the consequences of inadequate iodine intake in Belgium, focusing on undisputed and measurable health outcomes such as thyroid nodular disease and its associated morbidity (hyperthyroidism). METHODS: For the estimation of direct, indirect, medical, and nonmedical costs related to thyroid nodular diseases in Belgium, data from the Federal Public Service of Public Health, Food Chain Safety and Environment, the National Institute for Disease and Disability Insurance (RIZIV/INAMI), the Information Network about the prescription of reimbursable medicines (FARMANET), Intercontinental Marketing Services, and expert opinions were used. These costs translate into savings after implementation of the iodization program and are defined as costs due to thyroid nodular disease throughout the article. Costs related to the iodization program are referred to as program costs. Only figures dating from before the start of the intervention were exploited. Only adult and elderly people (≥18 years) were taken into account in this study because thyroid nodular diseases predominantly affect this age group. RESULTS: The yearly costs due to thyroid nodular diseases caused by mild iodine deficiency in the Belgian adult population are â¼38 million. It is expected that the iodization program will result in additional costs of â¼54,000 per year and decrease the prevalence of thyroid nodular diseases by 38% after a 4-5-year period. The net savings after establishment of the program are therefore estimated to be at least 14 million a year. CONCLUSIONS: Optimization of iodine intake in Belgium should be quite cost effective, if only considering its impact on nodular thyroid disease. There are likely added benefits relating to more optimal thyroid hormone influenced brain development that are more difficult to estimate but may be even more important.
Assuntos
Custos de Cuidados de Saúde , Iodo/administração & dosagem , Nódulo da Glândula Tireoide/economia , Nódulo da Glândula Tireoide/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Bélgica/epidemiologia , Análise Custo-Benefício , Estudos Transversais , Dinamarca/epidemiologia , Feminino , Previsões , Humanos , Hipertireoidismo/economia , Hipertireoidismo/epidemiologia , Hipertireoidismo/etiologia , Masculino , Pessoa de Meia-Idade , Prevalência , Nódulo da Glândula Tireoide/prevenção & controle , Adulto JovemRESUMO
BACKGROUND: There is no consensus on what constitutes appropriate methodology and timing for follow-up of patients after surgery for benign nodular disease. METHODS: A systematic review of the medical literature using evidence-based criteria was used to address the following four issues: (1) How often should patients who have undergone thyroidectomy for the treatment of benign nodular goiter be followed, and what constitutes appropriate follow-up? (2) What is the most appropriate method for detecting recurrent nodular thyroid disease? (3) Does thyroid hormone administration prevent recurrent nodular thyroid disease? (4) Does iodine administration prevent recurrent nodular thyroid disease? RESULTS: Altogether, 742 articles were found in MEDLINE using a keyword search strategy; we then narrowed them to 23 articles. There were a total of four articles with Level I data, five articles with Level II data, one article with Level III data, and 13 articles with Level IV or retrospective data. CONCLUSIONS: Based on the available data, it is our recommendation that patients undergoing thyroid lobectomy for benign nodular thyroid disease should be followed with an annual physical examination, neck ultrasonography, and serum thyroid-stimulating hormone (TSH) measurement. Patients undergoing total thyroidectomy should be followed with an annual physical examination and a serum TSH measurement. Routine thyroxine and/or iodine supplementation may be useful for preventing recurrence in patients from iodine-deficient regions.
Assuntos
Nódulo da Glândula Tireoide/cirurgia , Humanos , Iodo/uso terapêutico , Cuidados Pós-Operatórios/métodos , Prevenção Secundária , Nódulo da Glândula Tireoide/diagnóstico , Nódulo da Glândula Tireoide/prevenção & controle , Tireoidectomia , Oligoelementos/uso terapêuticoAssuntos
Dislipidemias/tratamento farmacológico , Dislipidemias/patologia , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Glândula Tireoide/efeitos dos fármacos , Nódulo da Glândula Tireoide/tratamento farmacológico , Nódulo da Glândula Tireoide/prevenção & controle , Feminino , Humanos , MasculinoRESUMO
BACKGROUND: Little information is available concerning the possible antiproliferative effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) on the thyroid gland. We have hypothesized that the antiproliferative effects of statins observed in thyroid cell lines in vitro may have a clinical counterpart that could be detected by investigating the prevalence and size of thyroid nodules in patients on long-term treatment with statins. METHODS: We retrospectively evaluated 135 dyslipidaemic patients receiving statin therapy continuously for at least 5 years, and 137 controls. All the subjects were submitted to ultrasound investigation of the thyroid gland, to establish prevalence, number and volume of thyroid nodules. RESULTS: Subjects treated with statins showed markedly lower prevalence of thyroid nodules (36.3%vs. 67.9%, P < 0.001), as well as reduced number and smaller total volume of lesions, as compared to the control group. A logistic regression analysis, taking into account age, sex, risk factors for the development of thyroid nodules and concomitant drug treatment, revealed that treatment with statins remained the only important predictor of the presence of thyroid nodules [odds ratio (OR) 0.312, 95% confidence interval (CI) 0.156-0.625, P < 0.001] besides risk factors. CONCLUSIONS: Our data provide the first circumstantial evidence of an association between HMG-CoA reductase inhibitor treatment and reduced prevalence, number and volume of thyroid nodules. This finding may be explained by an antiproliferative and/or pro-apoptotic effect of long-term statin treatment on thyroid cells, in vivo.